Free Trial
Memorial Day Savings! Save $100 on MarketBeat All Access
Claim Your Discount
Claim MarketBeat All Access Sale Promotion

CareDx (CDNA) 10K Form and Latest SEC Filings 2026

CareDx logo
$21.96 +0.39 (+1.80%)
As of 01:58 PM Eastern
This is a fair market value price provided by Massive. Learn more.

Latest CareDx SEC Filings & Recent Activity

CareDx (NASDAQ:CDNA) has submitted 705+ documents to the U.S. Securities and Exchange Commission (SEC) since 2017. For investors, these filings are the primary source of verified financial data — covering everything from annual revenue and debt levels in the 10-K, to material business events in 8-K current reports, to insider buying and selling activity in Form 4 disclosures. Key figures from these filings, including revenue, earnings, and cash flow, are summarized in CareDx's financial statements. The most recent filing was a Form 4 submitted on May 18, 2026.

Form 4
CareDx, Inc. Reports Ownership Change on May. 18, 2026

Form 4 filings disclose changes in stock ownership by company insiders, including purchases, sales, grants, and option exercises.

View insider ownership

8-K
CareDx Files Current Report on Apr. 28, 2026

An 8-K is filed when a material corporate event occurs, such as an acquisition, leadership change, or financial update.

View filing

CareDx SEC Filing History

Browse CareDx's complete SEC filing history using the filters below. Filter by form type - 10-K, 10-Q, 8-K, Form 4, and more - or set a custom date range to find a filing.

DateFilerForm TypeView
05/18/2026 3:05 PM
CareDx (1217234) Issuer
TORRES ARTHUR A (1251737) Reporting
Form 4
Statement of changes in beneficial ownership of securities  
05/15/2026 3:46 PM
CareDx (1217234) Subject
TORRES ARTHUR A (1251737) Reporting
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
05/14/2026 5:44 PM
CareDx (1217234) Subject
TORRES ARTHUR A (1251737) Reporting
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
05/06/2026 3:05 PM
CareDx (1217234) Issuer
Novack Jeffrey Adam (2019976) Reporting
Form 4
Statement of changes in beneficial ownership of securities  
05/05/2026 3:32 PM
CareDx (1217234) Subject
Novack Jeffrey Adam (2019976) Reporting
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
04/28/2026 4:07 PM
CareDx (1217234) Filer
Form S-3ASR
04/28/2026 3:05 PM
CareDx (1217234) Filer
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/27/2026 3:06 PM
CareDx (1217234) Filer
Form DEF 14A
04/23/2026 3:12 PM
CareDx (1217234) Filer
Form 8-K/A
04/22/2026 3:05 PM
CareDx (1217234) Issuer
Kennedy Keith (1543503) Reporting
Form 4
Statement of changes in beneficial ownership of securities  
04/20/2026 3:53 PM
CareDx (1217234) Issuer
Hanna John Walter JR (1781127) Reporting
Form 4
Statement of changes in beneficial ownership of securities  
04/16/2026 3:12 PM
CareDx (1217234) Subject
Hanna John Walter JR (1781127) Reporting
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
04/16/2026 5:05 AM
CareDx (1217234) Filer
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/07/2026 3:01 PM
CareDx (1217234) Issuer
Novack Jeffrey Adam (2019976) Reporting
Form 4
Statement of changes in beneficial ownership of securities  
04/03/2026 3:02 PM
CareDx (1217234) Issuer
Goldberg Michael (1366412) Reporting
Form 4
Statement of changes in beneficial ownership of securities  
04/03/2026 3:03 PM
CareDx (1217234) Issuer
Novack Jeffrey Adam (2019976) Reporting
Form 4
Statement of changes in beneficial ownership of securities  
04/03/2026 3:03 PM
CareDx (1217234) Issuer
Meng Jessica (2036499) Reporting
Form 4
Statement of changes in beneficial ownership of securities  
04/03/2026 3:04 PM
CareDx (1217234) Issuer
Kennedy Keith (1543503) Reporting
Form 4
Statement of changes in beneficial ownership of securities  
04/03/2026 3:05 PM
CareDx (1217234) Issuer
Hanna John Walter JR (1781127) Reporting
Form 4
Statement of changes in beneficial ownership of securities  
04/01/2026 3:10 PM
CareDx (1217234) Issuer
Goldberg Michael (1366412) Reporting
Form 4
Statement of changes in beneficial ownership of securities  
03/26/2026 3:41 PM
CareDx (1217234) Subject
VANGUARD GROUP INC (102909) Filed by
Form SCHEDULE 13G/A
02/12/2026 4:54 PM
CareDx (1217234) Subject
GAGNON SECURITIES LLC (1125725) Filed by
Form SCHEDULE 13G/A
02/09/2026 5:23 AM
CareDx (1217234) Subject
STATE STREET CORP (93751) Filed by
STATE STREET CORP (93751) Filed by
Form SCHEDULE 13G
01/23/2026 4:58 PM
CareDx (1217234) Issuer
Hanna John Walter JR (1781127) Reporting
Form 4
Statement of changes in beneficial ownership of securities  
01/20/2026 4:30 PM
CareDx (1217234) Issuer
Hanna John Walter JR (1781127) Reporting
Form 4
Statement of changes in beneficial ownership of securities  
01/15/2026 3:40 PM
CareDx (1217234) Subject
Hanna John Walter JR (1781127) Reporting
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
01/12/2026 6:08 AM
CareDx (1217234) Filer
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/07/2026 3:08 PM
CareDx (1217234) Issuer
Goldberg Michael (1366412) Reporting
Form 4
Statement of changes in beneficial ownership of securities  
12/18/2025 4:00 PM
CareDx (1217234) Filer
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/15/2025 3:02 PM
CareDx (1217234) Filer
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/05/2025 3:07 PM
CareDx (1217234) Issuer
Novack Jeffrey Adam (2019976) Reporting
Form 4
Statement of changes in beneficial ownership of securities  
12/04/2025 3:39 PM
CareDx (1217234) Subject
Novack Jeffrey Adam (2019976) Reporting
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
11/14/2025 10:21 AM
BAMCO INC /NY/ (1017918) Filed by
CareDx (1217234) Subject
Form SCHEDULE 13G
11/10/2025 3:14 PM
CareDx (1217234) Issuer
Novack Jeffrey Adam (2019976) Reporting
Form 4
Statement of changes in beneficial ownership of securities  
11/07/2025 4:22 PM
CareDx (1217234) Issuer
Novack Jeffrey Adam (2019976) Reporting
Form 4
Statement of changes in beneficial ownership of securities  
11/07/2025 3:37 PM
CareDx (1217234) Subject
Novack Jeffrey Adam (2019976) Reporting
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
11/05/2025 3:21 PM
CareDx (1217234) Subject
Jain Abhishek (1931277) Reporting
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
11/04/2025 3:09 PM
CareDx (1217234) Filer
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/04/2025 3:03 PM
CareDx (1217234) Issuer
Novack Jeffrey Adam (2019976) Reporting
Form 4
Statement of changes in beneficial ownership of securities  
10/31/2025 3:48 PM
CareDx (1217234) Subject
Jain Abhishek (1931277) Reporting
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
10/30/2025 1:55 PM
CareDx (1217234) Subject
VANGUARD GROUP INC (102909) Filed by
Form SCHEDULE 13G/A
A 17-year investing experiment investigated in Dublin (Ad)

Porter Stansberry flew the Porter and Co. team 3,300 miles to Dublin to investigate a 17-year investing experiment called Project Prophet - and documented everything on film. Rooted in the laws of physics, this quantitative approach challenges conventional wealth-building wisdom. With 17 years of verified data behind it, Porter calls it unlike anything he has seen in nearly 30 years in the business.tc pixel

Watch the full investigation and decide for yourself
10/24/2025 3:12 PM
CareDx (1217234) Issuer
Gunasekaran Suresh (2093388) Reporting
Form 3
Initial statement of beneficial ownership of securities  
10/24/2025 3:13 PM
CareDx (1217234) Issuer
Gunasekaran Suresh (2093388) Reporting
Form 4
Statement of changes in beneficial ownership of securities  
10/24/2025 3:06 PM
CareDx (1217234) Filer
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/07/2025 5:55 PM
CareDx (1217234) Issuer
Goldberg Michael (1366412) Reporting
Form 4
Statement of changes in beneficial ownership of securities  
09/15/2025 3:01 PM
CareDx (1217234) Issuer
Kennedy Keith (1543503) Reporting
Form 4
Statement of changes in beneficial ownership of securities  
09/15/2025 3:03 PM
CareDx (1217234) Issuer
Meng Jessica (2036499) Reporting
Form 4
Statement of changes in beneficial ownership of securities  
09/12/2025 4:09 PM
Bickerstaff George (1329646) Reporting
CareDx (1217234) Issuer
Form 4
Statement of changes in beneficial ownership of securities  
07/24/2025 3:28 PM
CareDx (1217234) Subject
GAGNON SECURITIES LLC (1125725) Filed by
Form SCHEDULE 13G
07/14/2025 3:01 PM
CareDx (1217234) Issuer
Novack Jeffrey Adam (2019976) Reporting
Form 4
Statement of changes in beneficial ownership of securities  
07/08/2025 5:39 PM
CareDx (1217234) Issuer
Goldberg Michael (1366412) Reporting
Form 4
Statement of changes in beneficial ownership of securities  
06/23/2025 3:30 PM
CareDx (1217234) Issuer
Valantine Hannah (1855608) Reporting
Form 4
Statement of changes in beneficial ownership of securities  
06/20/2025 3:30 PM
CareDx (1217234) Issuer
Maag Peter (1613855) Reporting
Form 4
Statement of changes in beneficial ownership of securities  
06/17/2025 3:30 PM
CareDx (1217234) Issuer
TORRES ARTHUR A (1251737) Reporting
Form 4
Statement of changes in beneficial ownership of securities  
06/17/2025 3:30 PM
CareDx (1217234) Issuer
COURNOYER CHRISTINE (1180466) Reporting
Form 4
Statement of changes in beneficial ownership of securities  
06/17/2025 3:30 PM
CareDx (1217234) Issuer
Valantine Hannah (1855608) Reporting
Form 4
Statement of changes in beneficial ownership of securities  
06/17/2025 3:30 PM
Bickerstaff George (1329646) Reporting
CareDx (1217234) Issuer
Form 4
Statement of changes in beneficial ownership of securities  
06/17/2025 3:30 PM
CareDx (1217234) Issuer
Riggsbee Richard Bryan (1621899) Reporting
Form 4
Statement of changes in beneficial ownership of securities  
06/17/2025 3:31 PM
CareDx (1217234) Issuer
Maag Peter (1613855) Reporting
Form 4
Statement of changes in beneficial ownership of securities  
06/13/2025 4:06 PM
CareDx (1217234) Issuer
HAGSTROM WILLIAM A (1042875) Reporting
Form 4
Statement of changes in beneficial ownership of securities  
06/12/2025 3:32 PM
CareDx (1217234) Filer
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/03/2025 3:30 PM
CareDx (1217234) Filer
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/30/2025 4:57 PM
CareDx (1217234) Issuer
HAGSTROM WILLIAM A (1042875) Reporting
Form 4
Statement of changes in beneficial ownership of securities  
05/29/2025 3:36 PM
CareDx (1217234) Issuer
Jain Abhishek (1931277) Reporting
Form 4
Statement of changes in beneficial ownership of securities  
(Data available from 1/1/2016 forward)

CareDx SEC Filings - Frequently Asked Questions

CareDx (CDNA) has submitted 705+ filings to the SEC since 2017. You can browse the complete history or filter by form type using the tools above.

CareDx's fiscal year ends on December 31. The company typically files its 10-K annual report by the end of February, covering the prior fiscal year's financial results. Key financial data from these reports is available on CareDx's financial statements page.

The most recent filing was a Form 4 submitted on May 18, 2026. This was an insider ownership change filed by 4 - CareDx, Inc. (0001217234) (Issuer).

SEC Filing Types: 10-K, 10-Q, 8-K and More

SEC filings are legally required disclosures that public companies submit to the U.S. Securities and Exchange Commission. Unlike press releases or earnings call transcripts, these documents are filed under legal obligation — meaning the financial data they contain is audited, standardized, and subject to penalties if materially false. For investors, that makes SEC filings the most reliable primary source available for evaluating a company's true financial position.

Yes. All SEC filings are publicly available through the SEC's EDGAR database and on financial research platforms like MarketBeat. Companies are required by law to make these disclosures accessible to all investors — meaning retail investors have access to the same source documents as institutional analysts.

A 10-K is an annual report containing audited financial statements and a full review of the company's business — it is the most comprehensive filing a company makes each year. A 10-Q is a shorter, unaudited quarterly update filed three times per year between annual reports. Investors typically use the 10-K for deep fundamental analysis and the 10-Q to track whether the company is on pace with its guidance mid-year.

The most important filing for fundamental investors. Filed once per year, the 10-K contains audited financial statements, revenue and earnings trends, debt obligations, risk factors, and management's own assessment of the business. Reading the risk factors section and comparing year-over-year financials can reveal issues that don't show up in analyst summaries.

An unaudited financial update filed three times per year (the 10-K covers Q4). Investors use 10-Qs to track whether guidance is on pace, monitor changes in cash flow or inventory, and catch any mid-year shifts in business conditions before they become headline news.

Filed within four business days of a material event — earnings releases, merger announcements, executive departures, or major asset sales. Because 8-Ks are filed before media coverage catches up, they are often the fastest way to get unfiltered information directly from the company on market-moving events.

Filed within two business days whenever an executive or director buys or sells company stock. Insider purchases — especially large or clustered buys — are often interpreted as a signal of management confidence. Insider selling is more ambiguous but worth monitoring for patterns, particularly around lock-up expirations or ahead of major announcements.


Related Companies and Tools


This page (NASDAQ:CDNA) was last updated on 5/22/2026 by MarketBeat.com Staff.
From Our Partners